UCHL1 and leiomyoma: In addition, LDN57444 is a reversible active UCH-L1 site-specific inhibitor that improves leiomyoma cell migration, gel contraction, and collagen synthesis, and reverses UCH-L1 overexpression of cardiac hyperplasia [171,172].